http://www.bbc.com/news/health-36416531
Citando:
"The mutation is in a gene called NR1H3, which makes a protein that acts as a switch controlling inflammation.
In MS the body's immune system mistakenly attacks the protective layer of myelin that surrounds nerve fibres in the brain and spinal cord, leading to muscle weakness and other symptoms."
(...)
"The researchers believe stopping the inflammation early might prevent or delay the disease. They already have drugs in mind that might do this by targeting the NR1H3 gene pathway.
These drugs are in development for other diseases, including cardiovascular disease and diabetes."
(...)
"[This MS] variant itself is rare and most people with MS won't have it. "